While these medications share the same active ingredient, they are approved for different uses and are prescribed at different dosages
The balanced unimolecular tri-agonist proved superior over any existing dual co-agonists and best-in-class monoagonists to reduce body weight, enhance glycemic control and reverse non-alcoholic steatohepatitis in preclinical research [25, 27, 28]
They provide balanced nutrition in controlled portions, perfectly complementing the appetite-suppressing effects of the injections
In early stages of starvation (beyond one week without food intake), when the last remnants of readily releasable fat are oxidized, heart and skeletal muscle will consume primarily ketone bodies to preserve glucose for use by the brain and erythrocytes
Lutikizumab, a new antibody drug that binds IL-1 was recently developed and is being studied in phase II and III trials for HS
For example, Bose et al